The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

BackgroundCirculating tumor DNA (ctDNA) levels and blood tumor mutation burden (bTMB) have a significant impact on the prognosis of tumor patients. However, their prognostic role in immune checkpoint inhibitors (ICIs) in cancer patients is still unclear.MethodsWe used the Review Manager software (ve...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jiayan Wei, Jia Feng, Yiming Weng, Zexi Xu, Yao Jin, Peiwei Wang, Xue Cui, Peng Ruan, Ruijun Luo, Na Li, Min Peng
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2021-10-01
Sarja:	Frontiers in Oncology
Aiheet:	ctDNA bTMB immune checkpoint inhibitor prognosis biomarker meta-analysis
Linkit:	https://www.frontiersin.org/articles/10.3389/fonc.2021.706910/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!